Literature DB >> 21126763

Human umbilical cord stromal stem cell express CD10 and exert contractile properties.

V A Farias1, J L Linares-Fernández, J L Peñalver, J A Payá Colmenero, G O Ferrón, E L Duran, R M Fernández, E G Olivares, F O'Valle, A Puertas, F J Oliver, J M Ruiz de Almodóvar.   

Abstract

BACKGROUND: It has been demonstrated that human umbilical cord stromal stem cells (UCSSCs) are bio-equivalent to bone marrow mesenchymal stem cells. However, little is known about their tissue origin or in vivo functions, and data on their expansion properties are limited due to early senescence in the culture methods described to date.
METHODS: UC sections and cultured UCSSCs were analyzed with a panel of 12 antibodies. UCSSCs were grown in low-FCS containing medium at 5% or 21% oxygen and were assayed for their clonogenic properties, karyotype stability, expression of specific cellular markers, and multi-lineage potential. UCSSC contractile properties were evaluated by using collagen gel contraction assays under cytokine stimulus.
RESULTS: Immunohistochemistry studies showed that the UCSSCs were derived from the Wharton's jelly and not from the vascular smooth muscle sheath of the blood vessels. UCSSC growth properties were increased in a 5% oxygen atmosphere in comparison to normoxic culture conditions. In both culture conditions, UCSSCs were CD14-, CD34-, and CD45-negative while expressing high levels of CD73, CD90 and CD105 and maintaining their differentiation potentialities. UCSSCs expressed alpha smooth muscle actin and behaved as functional myofibroblasts when cellular contraction was challenged with appropriate stimuli.
CONCLUSIONS: UCSCs are mesenchymal stem cells that reside in the perivascular area of Wharton's jelly and are phenotypically and functionally related to myofibroblasts.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126763     DOI: 10.1016/j.placenta.2010.11.003

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

Review 1.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

2.  A safe and efficient method to retrieve mesenchymal stem cells from three-dimensional fibrin gels.

Authors:  Bita Carrion; Isaac A Janson; Yen P Kong; Andrew J Putnam
Journal:  Tissue Eng Part C Methods       Date:  2013-08-14       Impact factor: 3.056

3.  Elimination of allogeneic multipotent stromal cells by host macrophages in different models of regeneration.

Authors:  Irina Arutyunyan; Andrey Elchaninov; Timur Fatkhudinov; Andrey Makarov; Evgeniya Kananykhina; Natalia Usman; Galina Bolshakova; Valeria Glinkina; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.

Authors:  Maria Carmen Arufe; Alexandre De la Fuente; Isaac Fuentes; Francisco Javier De Toro; Francisco Javier Blanco
Journal:  World J Orthop       Date:  2011-06-18

5.  Vitamin C stimulates human gingival stem cell proliferation and expression of pluripotent markers.

Authors:  Phuc Van Pham; Nga Yen Tran; Nhan Lu-Chinh Phan; Ngoc Bich Vu; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-20       Impact factor: 2.416

6.  Marker profile for the evaluation of human umbilical artery smooth muscle cell quality obtained by different isolation and culture methods.

Authors:  G Mazza; E Roßmanith; I Lang-Olip; D Pfeiffer
Journal:  Cytotechnology       Date:  2014-12-23       Impact factor: 2.058

7.  Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.

Authors:  Jiaqiang Ren; Huan Wang; Katherine Tran; Sara Civini; Ping Jin; Luciano Castiello; Ji Feng; Sergei A Kuznetsov; Pamela G Robey; Marianna Sabatino; David F Stroncek
Journal:  Cytotherapy       Date:  2015-04-14       Impact factor: 5.414

8.  Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.

Authors:  Lorena R Braid; Wei-Gang Hu; John E Davies; Les P Nagata
Journal:  Stem Cells Transl Med       Date:  2016-06-22       Impact factor: 6.940

9.  Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton's Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells.

Authors:  Arjunan Subramanian; Chui-Yee Fong; Arijit Biswas; Ariff Bongso
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 10.  Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.

Authors:  Dae-Won Kim; Meaghan Staples; Kazutaka Shinozuka; Paolina Pantcheva; Sung-Don Kang; Cesar V Borlongan
Journal:  Int J Mol Sci       Date:  2013-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.